Table 4.
Author, year | n | % stage IV | Optimal surgery | 5-year survival | ||
---|---|---|---|---|---|---|
Residual disease | % | Residual disease | % | |||
Eisenkop et al., 1998 [13] | 163 | 17% | 0 cm | 98.8% | 0 | 52% |
>0 | 29% | |||||
| ||||||
Scarabelli et al., 2000 [14] | 66 | 11% | <2 cm | 100% | 0 | 42.2% |
>0-1 | 21.3% | |||||
| ||||||
Chi et al., 2001 [15] | 282 | 23% | <1 cm | 26% | 0-1 | 50% |
>1-2 | 28% | |||||
>2 | 21% | |||||
| ||||||
Eisenkop, et al., 2003 [16] | 408 | 0% | <1 cm | 96% | 0-1 | 52% |
>1-2 | 30% | |||||
>2 | 0% | |||||
| ||||||
Present study | 340 | 22.75% | <1 cm | 40% | 0 | 55.4% |
>0-1 | 43.5% | |||||
>1 | 24.2% |